Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study.

Diabetes Ther · 2021 · PMC7947079 · PMID 33544356

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

borderline significantp = 0.05actually significant

The reduced rates of non-severe hypoglycaemia with regular human insulin were only borderline significant ( p = 0.05), with no clear differences among the insulin analogues lispro, glulisine and aspart.

also in 11,409 other papers

did not reach statistical significanceno p-value reported

Changes in lipid values over time in the FAS did not reach statistical significance for triglycerides or high-density lipoprotein (HDL) cholesterol.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.